World Preview 2024 – Pharma’s Growth Boost - Infographic | Evaluate
Pharma shifts to predictable trends, focusing on major drugs for big diseases. Evaluate’s 2030 forecast explores obesity and new tech.| Evaluate
Pharma shifts to predictable trends, focusing on major drugs for big diseases. Evaluate’s 2030 forecast explores obesity and new tech.| Evaluate
Pharma M&A and IPOs started strong in 2024 but saw significant drops in Q2, with fewer deals and only three companies going public.| Evaluate
Discover key strategies for forecasting rare diseases, affecting 300M+ people globally. Learn from case studies and epidemiological models in our guide.| Evaluate
Explore Evaluate's analysis of 200 top-selling drugs to uncover what makes billion-dollar blockbusters. Get the Billion Dollar Blueprint infographic now.| Evaluate
Discover how the loss of exclusivity for biologics by 2030 opens $120B in opportunities for biosimilars, shaping the industry's future.| Evaluate
Pharmacological intervention can shift excess body weight, but questions remain. Explore market size, pipeline value, and key insights.| Evaluate
Product Lifecycle Forecasting: This informative playbook covers everything you need to know about how forecasting demands and considerations evolve at each stage of a product's journey.| Evaluate
Explore how pharmaceutical companies add blockbuster drugs. Learn about internal development vs. acquisitions, strategic timing, top companies, and acquisition benefits.| Evaluate
